Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
Zepbound is indicated for adults with obesity (with a BMI of 30 kg/m 2 or greater), or those who are overweight (with a BMI of 27 kg/m 2 or greater) and also have weight-related medical problems such as hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea or cardiovascular disease, to lose weight and keep it off
Im not even at half a bottle yet and Im going on a month and a half with two applications a day
As estrogen levels decrease, insulin signaling can become less efficient, meaning the pancreas may need to release more insulin to manage the same amount of glucose
Dosage and Frequency: Higher doses or frequent sessions may increase the overall cost
Both approaches are clinically effective for weight management